Search Results
Jun 06, 2026, 11:08 ET MONDAY INVESTOR DEADLINE: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - MEDP
seek appointment as lead plaintiff in the Medpace class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other
More news about: Robbins Geller Rudman & Dowd LLP
Jun 06, 2026, 11:06 ET In HelloNation, Periodontics Expert Dr. Scott Kissel of Manhattan, NY, Details Why Microsurgical Techniques Matter in Periodontal Care
MANHATTAN, N.Y., June 6, 2026 /PRNewswire/ -- Why is precision so important when treating the gums and bone that support your teeth? That question is addressed in
More news about: HelloNation
Jun 06, 2026, 11:00 ET Clinical Amino Acid Profiles Anchor PureHealth Research's New Natural Peptides Supplements
natural peptide supplements.About PureHealth ResearchPureHealth Research is dedicated to advancing proactive health through science-backed nutrition. Each formula is approved by credentialed medical experts and built on scientifically validated research and premium ingredients,
More news about: PureHealth Research LLC
Jun 06, 2026, 11:00 ET MONDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Stellantis N.V. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - STLA
seek appointment as lead plaintiff in the Stellantis class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class
More news about: Robbins Geller Rudman & Dowd LLP
Jun 06, 2026, 11:00 ET PureHealth Research Highlights Growing Consumer Interest in Lymphatic Wellness and Botanical Support
Understanding Lymphatic Function and Botanical ResearchThe lymphatic system is an intricate network that runs parallel to the bloodstream and plays an important role in moving fluid and immune cells throughout the body. Burdock
More news about: PureHealth Research LLC
Jun 06, 2026, 10:30 ET INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Zoetis Inc. (ZTS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
seek appointment as lead plaintiff in the Zoetis class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other
More news about: Robbins Geller Rudman & Dowd LLP
Jun 06, 2026, 10:20 ET AVAV INVESTOR NOTICE: AeroVironment, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
appointment as lead plaintiff in the AeroVironment class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class
More news about: Robbins Geller Rudman & Dowd LLP
Jun 06, 2026, 09:07 ET People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more likely to achieve greater than 5% weight loss than those who were switched to tirzepatide, in real-world data
There is no reason to suspect these differences will differentially bias the results.1About Novo Nordisk Novo Nordisk is a leading global healthcare company with a heritage of more than 100 years in diabetes care. Building on this foundation, our purpose is to drive
More news about: Novo Nordisk
Jun 06, 2026, 09:01 ET People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more likely to achieve greater than 5% weight loss than those who were switched to tirzepatide, in real-world data
There is no reason to suspect these differences will differentially bias the results.1About Novo Nordisk Novo Nordisk is a leading global healthcare company with a heritage of more than 100 years in diabetes care. Building on this foundation, our purpose is to drive
More news about: Novo Nordisk
Jun 06, 2026, 09:00 ET New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis
Diabetic ketoacidosis (DKA) can develop quickly and is not always easy to detect earlyKetone monitoring is not yet routine in diabetes care, which may contribute to missed warning signs of DKA and delays in interventionNearly 60% of pediatric hospitalizations for
More news about: Abbott
Jun 06, 2026, 09:00 ET Ultra-Long-Acting Injectable GLP-1 RA Shows Promise for Supporting Weight Management in Individuals With and Without Type 2 Diabetes
monthly dosing options.Data Highlights the Promise of Monthly Injection as an Effective Obesity Treatment for Weight LossVESPER-3 is a 2b trial evaluating whether berobenatide can successfully transition from once-weekly to once-monthly dosing while still maintaining weight loss and
More news about: American Diabetes Association
Jun 06, 2026, 07:51 ET Chandigarh University holds 8th CU Online Annual Convocation; 363 Students Degrees Awarded
going to happen. Infact, AI is going to create more and more opportunities all across the world for the learners who adapt and upskill themselves. The world is changing rapidly. If there has ever been a better time for learners in India to prepare themselves for the future, this is the time. I am pleased
More news about: Chandigarh University
Jun 06, 2026, 06:11 ET Deepak Group Goes Beyond Green with hands-On Mangrove Restoration
anchoring coastlines against erosion, and providing critical nursery grounds for marine biodiversity. Their loss is irreversible on any human timescale. Their restoration, when done right, is one of the highest-impact nature-based interventions available. Mangroves become the cradle for flora and fauna
More news about: Deepak Nitrite Limited
Jun 06, 2026, 06:00 ET Leading Vision Insurance for Glasses (2026): VSP Individual Vision Plans Named Top Plan for Frames and Lens Coverage by Better Business Advice
manage recurring expenses such as glasses and lens upgrades.Frame Allowances and Flexible OptionsA key factor in the recognition is VSP Individual Vision Plans'
More news about: BetterBusinessAdvice.com
Jun 06, 2026, 03:47 ET Shuja Rabbani Positions Human Resources as a Strategic Force for the GCC's Next Era of Business Transformation
only if we help people and organizations overcome resistance, build trust, and lead people through change," said Rabbani. "The future of HR is not administration. It is enterprise transformation."A strong advocate for psychological safety and responsible AI adoption in the workplace, Rabbani has also
More news about: Shuja Rabbani
Jun 05, 2026, 23:03 ET PICS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against PicS N.V. and Announces Opportunity for Investors with Substantial Losses to Lead the PicS N.V. Class Action Lawsuit
seek appointment as lead plaintiff in the PicS N.V. class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other
More news about: Robbins Geller Rudman & Dowd LLP
Jun 05, 2026, 22:12 ET NYT Investors Have the Opportunity to Join Investigation of The New York Times Company with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in The New York Times Company ("New York Times" or "the Company") (NYSE:
More news about: The Schall Law Firm
Jun 05, 2026, 22:00 ET SES AI Corporation Securities Fraud Class Action Result of Weak Revenue Guidance and 37% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
they purchased or otherwise acquired the Company's securities between January 29, 2025 and March 4, 2026, inclusive (the "Class Period"). This action is pending in the United States District Court for the District of Massachusetts.
More news about: Kahn Swick & Foti, LLC
Jun 05, 2026, 22:00 ET Sportradar Securities Fraud Class Action Result of Compliance Misrepresentations and 22% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
or otherwise acquired the Company's Class A ordinary shares between November 7, 2024 and April 21, 2026, inclusive (the "Class Period"). This action is pending in the United States District Court for the Southern District of New York.
More news about: Kahn Swick & Foti, LLC
Jun 05, 2026, 22:00 ET Roblox Investigation Initiated: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Roblox Corporation - RBLX
2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), is investigating claims on behalf of investors of
More news about: Kahn Swick & Foti, LLC
Jun 05, 2026, 22:00 ET Lockheed Martin Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lockheed Martin Corporation - LMT
failing to disclose material information during the Class Period in violation of federal securities laws, which remains ongoing.KSF's investigation is focusing on whether Lockheed's officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws. If
More news about: Kahn Swick & Foti, LLC
Jun 05, 2026, 21:02 ET Think Together Awards 2026 Beyond Think Together Scholarships to Ten High School Seniors Across the State
as they pursue their dreams and prepare for what comes next," said Think Together Founder and CEO Randy Barth. "That is why celebrating this year's graduates and scholarship recipients is so special. We are proud of all they have accomplished and excited to see where their futures take them."In
More news about: Think Together
Jun 05, 2026, 20:30 ET Ractigen Therapeutics Announces ADA 2026 Late-Breaking Presentation Highlighting saRNA as a New Frontier in Obesity Control
unlock Ucp1-driven thermogenesis, Ractigen Therapeutics is establishing a highly differentiated therapeutic mechanism that can act as a standalone treatment or as the ideal combination partner for existing incretin therapies.The abstract is available online via the journal Diabetes® website.Presentation
More news about: Ractigen Therapeutics
Jun 05, 2026, 20:30 ET 46 Greenberg Traurig Attorneys Recognized in 2026 IAM Patent 1000
Firm" by general counsel for trust and relationship management, Greenberg Traurig is consistently ranked among the top firms on the Am Law Global 100, NLJ 500, and Law360 400. Greenberg Traurig is also known for its philanthropic giving, culture, innovation, and pro bono work. Web:
More news about: Greenberg Traurig, LLP
Jun 05, 2026, 19:33 ET Ambrosia Biosciences Announces Preclinical Data Supporting Differentiated Profile of AMB-702, its Novel Small Molecule GLP-1 Receptor Agonist Development Candidate
Ambrosia Biosciences Inc. is a privately held drug discovery company developing next-generation oral small molecule therapies for obesity and other metabolic disorders. By integrating structurally-enabled drug design with in-house medicinal chemistry and biology capabilities, Ambrosia is advancing a complementary
More news about: Ambrosia Biosciences